← Leaderboards
Evan Dale Abel
University Of Iowa
$18,300,141
Attributed
$25,259,446
Total exposure
20
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,259,446 · 20
By mechanism
R01$13,237,788 · 9
T32$2,667,769 · 2
R33$2,182,075 · 1
U01$1,825,394 · 1
R25$1,730,544 · 1
R61$1,461,600 · 1
Top collaborators
- Yang K Xiang8 shared
- Andrew W. Norris6 shared
- Val C Sheffield5 shared
- Matthew Thomas Rondina3 shared
- Joshua J Joseph2 shared
- Andrew Scott Weyrich2 shared
- Steven P Gygi1 shared
- Jared P Rutter1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Kamal Rahmouni$7,611,926
- Bing Li$13,995,652
- Rajan Sah$10,133,831
- Lyse A Norian$3,712,281
- Matthew Joseph Potthoff$9,849,041
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusFunctional DisorderAnimalsInsulinMouse ModelObesityMediatingChronicBaseLinkCollaborationsSignal TransductionInsulin ResistanceCardiacIn VivoMolecularHeartProgramsResponseTraining ProgramsMyocardialCardiac MyocytesNon-Insulin-Dependent Diabetes MellitusMetabolic
Grant awards (74)
NNMT Inhibition for treating heart failure$736,089
R01 · FY2025 · HL · contact PI
Shaping Cardiac Immuno-metabolic Homeostasis by the Lysosome$612,186
R01 · FY2025 · HL
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$421,653
R01 · FY2025 · DK
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$449,766
R01 · FY2024 · DK
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$143,890
R25 · FY2024 · DK · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$468,507
R01 · FY2023 · DK
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$145,800
R25 · FY2023 · DK · contact PI
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation$733,453
R33 · FY2022 · HL · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$468,501
R01 · FY2022 · DK
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$142,146
R25 · FY2022 · DK · contact PI
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation$724,311
R33 · FY2021 · HL · contact PI
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes$468,501
R01 · FY2021 · DK
Diabetes Research Training Program$449,959
T32 · FY2021 · DK · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$142,146
R25 · FY2021 · DK · contact PI
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation$724,311
R33 · FY2020 · HL · contact PI
Diabetes Research Training Program$416,856
T32 · FY2020 · DK · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$142,146
R25 · FY2020 · DK · contact PI
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation$724,241
R61 · FY2019 · HL · contact PI
Diabetes Research Training Program$404,275
T32 · FY2019 · DK · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$142,146
R25 · FY2019 · DK · contact PI
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation$737,359
R61 · FY2018 · HL · contact PI
Insulin Inhibition of beta-AR Signaling in the Myocardium$594,902
R01 · FY2018 · HL · contact PI
Diabetes Research Training Program$409,535
T32 · FY2018 · DK · contact PI
Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR Signaling$386,875
R01 · FY2018 · HL · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Development for Underrepresented Trainees and Junior Faculty$144,306
R25 · FY2018 · DK · contact PI
Diabetes Research Training Program$64,025
T32 · FY2018 · DK · contact PI
Insulin Inhibition of beta-AR Signaling in the Myocardium$594,902
R01 · FY2017 · HL · contact PI
Diabetes Research Training Program$390,743
T32 · FY2017 · DK · contact PI
Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR Signaling$386,875
R01 · FY2017 · HL · contact PI
Insulin Inhibition of beta-AR Signaling in the Myocardium$594,618
R01 · FY2016 · HL · contact PI
Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR Signaling$386,250
R01 · FY2016 · HL · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Developm$149,605
R25 · FY2016 · DK · contact PI
Insulin Inhibition of beta-AR Signaling in the Myocardium$614,709
R01 · FY2015 · HL · contact PI
Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR Signaling$397,938
R01 · FY2015 · HL · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Developm$147,623
R25 · FY2015 · DK · contact PI
Insulin Resistance and Myocardial Autophagy$369,950
R01 · FY2014 · HL · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Developm$145,297
R25 · FY2014 · DK · contact PI
Insulin Resistance and Myocardial Autophagy$355,810
R01 · FY2013 · HL · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Developm$135,834
R25 · FY2013 · DK · contact PI
Insulin Resistance and Myocardial Autophagy$373,750
R01 · FY2012 · HL · contact PI
Interdisciplinary Training Program in Metabolism$243,913
T32 · FY2012 · DK · contact PI
Future Leaders Advancing Research in Endocrinology (FLARE): Professional Developm$149,605
R25 · FY2012 · DK · contact PI
Interdisciplinary Training Program in Metabolism$57,316
T32 · FY2012 · DK · contact PI
Functional Genomics of the Mitochondrial Proteome$499,754
R24 · FY2011 · DK · contact PI
Insulin Resistance and Myocardial Autophagy$374,376
R01 · FY2011 · HL · contact PI
Insulin Signaling and the Heart in Diabetes$321,911
R01 · FY2011 · DK · contact PI
Interdisciplinary Training Program in Metabolism$231,147
T32 · FY2011 · DK · contact PI
University of Utah Biomedical Research Core Center (P30) in Metabolism and CVD$400,910
P30 · FY2010 · HL · contact PI
Modeling Diabetic Cardiomyopathy and Microangiopathy$362,911
U01 · FY2010 · HL · contact PI
Insulin Signaling and the Heart in Diabetes$327,338
R01 · FY2010 · DK · contact PI
University of Utah Biomedical Research Core Center (P30) in Metabolism and CVD$438,297
P30 · FY2009 · HL · contact PI
Modeling Diabetic Cardiomyopathy and Microangiopathy$362,911
U01 · FY2009 · HL · contact PI
Modeling Diabetic Cardiomyopathy and Microangiopathy$362,911
U01 · FY2008 · HL · contact PI
Modeling Diabetic Cardiomyopathy and Microangiopathy$362,911
U01 · FY2007 · HL · contact PI
Insulin resistance and cardiac dysfunction in obesity$354,382
R01 · FY2007 · HL · contact PI
Insulin Signaling and the Heart in Diabetes$354,382
R01 · FY2007 · HL · contact PI
Insulin Signaling and the Heart in Diabetes$383,656
R01 · FY2006 · HL · contact PI
Modeling Diabetic Cardiomyopathy and Microangiopathy$373,750
U01 · FY2006 · HL · contact PI
Insulin resistance and cardiac dysfunction in obesity$364,967
R01 · FY2006 · HL · contact PI
Targeting Antioxidant Therapy to Cardiac Mitochondria$218,980
R21 · FY2006 · DK · contact PI
Insulin resistance and cardiac dysfunction in obesity$442,520
R01 · FY2005 · HL
Insulin Signaling and the Heart in Diabetes$373,750
R01 · FY2005 · HL
Targeting Antioxidant Therapy to Cardiac Mitochondria$186,875
R21 · FY2005 · DK
Insulin Signaling and the Heart in Diabetes$26,161
R01 · FY2005 · HL
Insulin resistance and cardiac dysfunction in obesity$442,520
R01 · FY2004 · HL
Insulin Signaling and the Heart in Diabetes$373,750
R01 · FY2004 · HL
Insulin resistance and cardiac dysfunction in obesity$28,655
R01 · FY2004 · HL
Insulin resistance and cardiac dysfunction in obesity$373,959
R01 · FY2003 · HL
Insulin resistance and cardiac dysfunction in obesity$13,679
R01 · FY2003 · HL
IN VIVO ANALYSIS OF THYROID HORMONE ACTION$121,230
K08 · FY2001 · DK
PHYSIOLOGICAL CONSEQUENCES OF ENHANCED GLUT4 EXPRESSION$83,500
R03 · FY2001 · DK
IN VIVO ANALYSIS OF THYROID HORMONE ACTION$95,528
K08 · FY2000 · DK
PHYSIOLOGICAL CONSEQUENCES OF ENHANCED GLUT4 EXPRESSION$83,500
R03 · FY2000 · DK
IN VIVO ANALYSIS OF THYROID HORMONE ACTION$25,702
K08 · FY2000 · DK